Paper38947759
Personalized surgical recommendations and quantitative therapeutic insights for patients with metastatic breast cancer: Insights from deep learning.
Zhu E and 10 others. Cancer Innov, 2024. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Personalized surgical recommendations and quantitative therapeutic insights for patients with metastatic breast cancer: Insights from deep learning. Papers, record 38947759. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38947759
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Personalized surgical recommendations and quantitative therapeutic insights for patients with metastatic breast cancer: Insights from deep learning.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References40
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34678411 | ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer. | Ann Oncol | 2021 | https://conductscience.org/library/papers/34678411 | PubMed |
| 2 | 27382334 | Contralateral prophylactic mastectomy: current perspectives. | Int J Womens Health | 2016 | https://conductscience.org/library/papers/27382334 | PubMed |
| 3 | 19398188 | Surgical resection of the primary tumour is associated with improved survival in patients with distant metastatic breast cancer at diagnosis. | Eur J Surg Oncol | 2009 | https://conductscience.org/library/papers/19398188 | PubMed |
| 4 | 35950555 | Delay in the initiation of adjuvant chemotherapy in patients with breast cancer with mastectomy with or without immediate breast reconstruction. | BJS Open | 2022 | https://conductscience.org/library/papers/35950555 | PubMed |
| 5 | 28522448 | Estimation of the Number of Women Living with Metastatic Breast Cancer in the United States. | Cancer Epidemiol Biomarkers Prev | 2017 | https://conductscience.org/library/papers/28522448 | PubMed |
| 6 | 37929878 | Reasoning and causal inference regarding surgical options for patients with low-grade gliomas using machine learning: A SEER-based study. | Cancer Med | 2023 | https://conductscience.org/library/papers/37929878 | PubMed |
| 7 | 17950122 | The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. | Prev Med | 2007 | https://conductscience.org/library/papers/17950122 | PubMed |
| 8 | 36088284 | Is laterality in breast Cancer still worth studying? Local experience in Bahrain. | BMC Cancer | 2022 | https://conductscience.org/library/papers/36088284 | PubMed |
| 9 | 27576011 | Why Are There So Many Mastectomies in the United States? | Annu Rev Med | 2017 | https://conductscience.org/library/papers/27576011 | PubMed |
| 10 | 15737554 | Does surgery unfavourably perturb the "natural history" of early breast cancer by accelerating the appearance of distant metastases? | Eur J Cancer | 2005 | https://conductscience.org/library/papers/15737554 | PubMed |
| 11 | 27865536 | Breast cancer. | Lancet | 2017 | https://conductscience.org/library/papers/27865536 | PubMed |
| 12 | 38947759 | Personalized surgical recommendations and quantitative therapeutic insights for patients with metastatic breast cancer: Insights from deep learning. | Cancer Innov | 2024 | https://conductscience.org/library/papers/38947759 | PubMed |
| 13 | 36816575 | Analyzing and predicting the risk of death in stroke patients using machine learning. | Front Neurol | 2023 | https://conductscience.org/library/papers/36816575 | PubMed |
| 14 | 34325907 | Metastatic breast cancer: Who benefits from surgery? | Am J Surg | 2022 | https://conductscience.org/library/papers/34325907 | PubMed |
| 15 | 17687611 | Surgical resection of the primary tumor is associated with increased long-term survival in patients with stage IV breast cancer after controlling for site of metastasis. | Ann Surg Oncol | 2007 | https://conductscience.org/library/papers/17687611 | PubMed |
| 16 | 10613347 | The surveillance, epidemiology, and end results program: a national resource. | Cancer Epidemiol Biomarkers Prev | 1999 | https://conductscience.org/library/papers/10613347 | PubMed |
| 17 | 17085652 | Circulating tumor cells versus imaging--predicting overall survival in metastatic breast cancer. | Clin Cancer Res | 2006 | https://conductscience.org/library/papers/17085652 | PubMed |
| 18 | 30770453 | Metalearners for estimating heterogeneous treatment effects using machine learning. | Proc Natl Acad Sci U S A | 2019 | https://conductscience.org/library/papers/30770453 | PubMed |
| 19 | 14662433 | Excisional surgery for cancer cure: therapy at a cost. | Lancet Oncol | 2003 | https://conductscience.org/library/papers/14662433 | PubMed |
| 20 | 25466502 | Is there a role for locoregional surgery in stage IV breast cancer? | Breast | 2015 | https://conductscience.org/library/papers/25466502 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42490932 | Development and validation of an interpretable machine learning-based predictive model for breast cancer bone metastasis. | Front Oncol | 2026 | https://conductscience.org/library/papers/42490932 | PubMed |
| 42317741 | Why health recommender systems struggle to reach clinical practice: A lifecycle-oriented systematic review. | iScience | 2026 | https://conductscience.org/library/papers/42317741 | PubMed |
| 40696372 | ALOXE3 expression predicts poor prognosis and modulates immune infiltration in colon adenocarcinoma. | World J Surg Oncol | 2025 | https://conductscience.org/library/papers/40696372 | PubMed |
| 39803647 | Deep learning to optimize radiotherapy decisions for elderly patients with early-stage breast cancer: a novel approach for personalized treatment. | Am J Cancer Res | 2024 | https://conductscience.org/library/papers/39803647 | PubMed |
| 39163387 | Utilizing machine learning to tailor radiotherapy and chemoradiotherapy for low-grade glioma patients. | PLoS One | 2024 | https://conductscience.org/library/papers/39163387 | PubMed |
| 38947759 | Personalized surgical recommendations and quantitative therapeutic insights for patients with metastatic breast cancer: Insights from deep learning. | Cancer Innov | 2024 | https://conductscience.org/library/papers/38947759 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38947759
GET https://conductscience.org/api/papers/v1/38947759/references?page=2